Heme oxygenase-1 in tumors: is it a false friend?
Reads0
Chats0
TLDR
Inhibition of HO-1 can be suggested as a potential therapeutic approach sensitizing tumors to radiation, chemotherapy, or photodynamic therapy, as well as an enzyme facilitating tumor progression.Abstract:
Heme oxygenase-1 (HO-1) catalyzes the oxidation of heme to biologically active products: carbon monoxide (CO), biliverdin, and ferrous iron. It participates in maintaining cellular homeostasis and plays an important protective role in the tissues by reducing oxidative injury, attenuating the inflammatory response, inhibiting cell apoptosis, and regulating cell proliferation. HO-1 is also an important proangiogenic mediator. Most studies have focused on the role of HO-1 in cardiovascular diseases, in which its significant, beneficial activity is well recognized. A growing body of evidence indicates, however, that HO-1 activation may play a role in carcinogenesis and can potently influence the growth and metastasis of tumors. HO-1 is very often upregulated in tumor tissues, and its expression is further increased in response to therapies. Although the exact effect can be tissue specific, HO-1 can be regarded as an enzyme facilitating tumor progression. Accordingly, inhibition of HO-1 can be suggested as a p...read more
Citations
More filters
Journal ArticleDOI
Oxidative Stress, Inflammation, and Cancer: How Are They Linked?
TL;DR: Observations to date suggest that oxidative stress, chronic inflammation, and cancer are closely linked.
Journal ArticleDOI
Role of glutathione in cancer progression and chemoresistance.
Nicola Traverso,Roberta Ricciarelli,Mariapaola Nitti,Barbara Marengo,Anna Lisa Furfaro,Maria Adelaide Pronzato,Umberto M. Marinari,Cinzia Domenicotti +7 more
TL;DR: The present review highlights the role of GSH and related cytoprotective effects in the susceptibility to carcinogenesis and in the sensitivity of tumors to the cytotoxic effects of anticancer agents.
Journal ArticleDOI
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Xiao Jun Wang,Zheng Sun,Nicole Villeneuve,Shirley L. Zhang,Fei Zhao,Yanjie Li,Weimin Chen,Xiaofang Yi,Wenxin Zheng,Georg T. Wondrak,Pak Kin Wong,Donna D. Zhang +11 more
TL;DR: It is reported that inhibition of NF-E2-related factor 2 (Nrf2) may be a promising strategy to combat chemoresistance, and evidence is provided that the strategy of using Nrf2 inhibitors to increase efficacy of chemotherapeutic agents is not limited to certain cancer types or anticancer drugs and thus can be applied during the course of chemotherapy to treat many cancer types.
Journal ArticleDOI
Dual roles of Nrf2 in cancer
TL;DR: In response to oxidative stress, the transcription factor NF-E2-related factor 2 (Nrf2) controls the fate of cells through transcriptional upregulation of antioxidant response element (ARE)-bearing genes, including those encoding endogenous antioxidants, phase II detoxifying enzymes, and transporters.
Journal ArticleDOI
Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features
Luisa M. Solis,Carmen Behrens,Wenli Dong,Milind Suraokar,Natalie C. Ozburn,Cesar A. Moran,Alejandro H. Corvalan,Shyam Biswal,Stephen G. Swisher,B. Nebiyou Bekele,John D. Minna,David J. Stewart,Ignacio I. Wistuba +12 more
TL;DR: Increased expression of Nrf2 and decreased expression of Keap1 are common abnormalities in NSCLC and are associated with a poor outcome, and nuclear expression ofNrf2 in malignant lung cancer cells may play a role in resistance to platinum-based treatment in squamous cell carcinoma.
References
More filters
Journal ArticleDOI
Inflammation and cancer
Lisa M. Coussens,Zena Werb +1 more
TL;DR: It is now becoming clear that the tumour microenvironment, which is largely orchestrated by inflammatory cells, is an indispensable participant in the neoplastic process, fostering proliferation, survival and migration.
Journal ArticleDOI
THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases
TL;DR: This review highlights the current information on molecular and biochemical properties of HO-1 and HO-2 and addresses the possible mechanisms for mutual regulatory interactions between the CO- and NO-generating systems.
Journal ArticleDOI
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Leo E. Otterbein,Leo E. Otterbein,Fritz H. Bach,Jawed Alam,Miguel P. Soares,Hong-Tao Lu,Mark Allen Wysk,Roger J. Davis,Richard A. Flavell,Augustine M.K. Choi,Augustine M.K. Choi +10 more
TL;DR: It is demonstrated here that carbon monoxide, a by-product of heme catabolism by heme oxygenase, mediates potent anti-inflammatory effects and may have an important protective function in inflammatory disease states and thus has potential therapeutic uses.
Journal ArticleDOI
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer.
Ping Ji,Sven Diederichs,Wenbing Wang,Sebastian Böing,Ralf Metzger,Paul M. Schneider,Nicola Tidow,Burkhard Brandt,Horst Buerger,Etmar Bulk,Michael Thomas,Wolfgang E. Berdel,Hubert Serve,Carsten Müller-Tidow +13 more
TL;DR: The identification of MALAT-1 emphasizes the potential role of noncoding RNAs in human cancer and contributes to the identification of early-stage NSCLC patients that are at high risk to develop metastasis.